107 related articles for article (PubMed ID: 22641484)
1. The use of rituximab therapy in patients with acquired factor V inhibitors.
Navarrete MA; van der Meer FJ; Damiani G; Diaz A; Eikenboom J
Am J Hematol; 2012 Aug; 87(8):826-7. PubMed ID: 22641484
[No Abstract] [Full Text] [Related]
2. Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.
Bomgaars L; Carberry K; Fraser C; West A; Teruya J
Congenit Heart Dis; 2010; 5(3):303-8. PubMed ID: 20576051
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of low-dose rituximab in a refractory acquired factor VIII inhibitor case secondary to pemphigus.
Gao Y; Liu S; Ma G; Lv L; Su Y
Acta Haematol; 2012; 127(1):20-2. PubMed ID: 21996575
[TBL] [Abstract][Full Text] [Related]
4. Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A?
Castaman G; Tosetto A
Haemophilia; 2011 Sep; 17(5):817-8. PubMed ID: 21371198
[No Abstract] [Full Text] [Related]
5. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of acquired haemophilia in a patient with bullous pemphigoid with single-dosing regimen of rituximab.
Zhang X; Guo J; Guo X; Pan J
Haemophilia; 2012 Sep; 18(5):e393-5. PubMed ID: 22823057
[No Abstract] [Full Text] [Related]
7. Successful management of a possible antibiotic-related acquired factor V inhibitor: a case report and review of the literature.
Motwani P; Howard L; Ali SS
Acta Haematol; 2013; 129(3):182-4. PubMed ID: 23257771
[TBL] [Abstract][Full Text] [Related]
8. Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer.
Caers J; Reekmans A; Jochmans K; Naegels S; Mana F; Urbain D; Reynaert H
Endoscopy; 2003 Jun; 35(6):542-4. PubMed ID: 12783357
[TBL] [Abstract][Full Text] [Related]
9. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.
Savage WJ; Kickler TS; Takemoto CM
Pediatr Blood Cancer; 2007 Dec; 49(7):1025-9. PubMed ID: 16526049
[TBL] [Abstract][Full Text] [Related]
10. A multicenter pilot study to estimate the prevalence of bovine and human coagulation antibodies in the general US population.
Fareed J; Paterson CA; Crean SM
Clin Appl Thromb Hemost; 2011 Apr; 17(2):164-70. PubMed ID: 21078614
[TBL] [Abstract][Full Text] [Related]
11. Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases.
Li F; Shu K; Liu J; Shen C; Wang X; Zhang Z; Jiang M
Acta Haematol; 2019; 141(3):148-150. PubMed ID: 30783058
[No Abstract] [Full Text] [Related]
12. Acquired factor V inhibitors: a systematic review.
Franchini M; Lippi G
J Thromb Thrombolysis; 2011 May; 31(4):449-57. PubMed ID: 21052780
[TBL] [Abstract][Full Text] [Related]
13. Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure.
Donohoe K; Levine R
J Thromb Haemost; 2015 Oct; 13(10):1787-9. PubMed ID: 26270511
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
Rodgers GM
J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
[TBL] [Abstract][Full Text] [Related]
15. Acquired factor V inhibitor-related severe bleeding due to unformed prothrombinase complex.
Mitsuhashi T; Takamiya O
Thromb Res; 2018 Nov; 171():81-83. PubMed ID: 30267973
[No Abstract] [Full Text] [Related]
16. The coagulation cascade and surgical hemostasis. Introduction.
Voils SA
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):1S. PubMed ID: 19558277
[No Abstract] [Full Text] [Related]
17. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
18. Different manifestations of patients with inhibitors against prothrombin and thrombin.
Tang N; Li D
J Thromb Thrombolysis; 2020 Jan; 49(1):164-167. PubMed ID: 31549352
[No Abstract] [Full Text] [Related]
19. Acquired inhibitors to factors V and X after exposure to topical thrombin: interference with monitoring of low molecular weight heparin and warfarin.
Israels SJ; Leaker MT
J Pediatr; 1997 Sep; 131(3):480-3. PubMed ID: 9329435
[TBL] [Abstract][Full Text] [Related]
20. Acquired factor V inhibitor in a context of sepsis and disseminated intravascular coagulation.
Tessier-Marteau A; Croquefer S; Meziani F; Cau S; Asfar P; Macchi L
Am J Hematol; 2010 Feb; 85(2):145-6. PubMed ID: 20052744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
